Jamie Irisari
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Genetic Associations and Epidemiology
Papers in
-
- COVID-19 Clinical Research Studies 5
- Genetics 2
- Genetic Associations and Epidemiology 2
Jamie Irisari
8 papers receiving 530 citations
Jamie Irisari's Hit Papers
Peers
Comparison fields: 5 of 55
- Infectious Diseases 298
- Genetics 94
- Immunology 35
- Neurology 23
- Epidemiology 40
Countries citing papers authored by Jamie Irisari
This map shows the geographic impact of Jamie Irisari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamie Irisari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamie Irisari more than expected).
Fields of papers citing papers by Jamie Irisari
This network shows the impact of papers produced by Jamie Irisari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamie Irisari. The network helps show where Jamie Irisari may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 2 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 3 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 4 | 2023 | 60 | |
| 5 | 2023 | 25 | |
| 6 | 2024 | 24 | |
| 7 | 2025 | 5 | |
| 8 | 2025 | 2 |
About Jamie Irisari
Jamie Irisari is a scholar working on Infectious Diseases, Genetics, Surgery, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 8 papers that have together received 556 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), Genetic Associations and Epidemiology (2 papers) and Kawasaki Disease and Coronary Complications (1 paper). The work is most often cited by research in Infectious Diseases (298 citations), Genetics (94 citations), Immunology (35 citations), Neurology (23 citations) and Epidemiology (40 citations). Their work appears in journals such as The Lancet, Nature, EClinicalMedicine, The Lancet Infectious Diseases and The Lancet Diabetes & Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.